Luca Mologni
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments 13
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 11
- Oncology top 5%
- Cancer-related Molecular Pathways 12
- Lung Cancer Research Studies 11
- Rheumatology top 2%
- Molecular Biology top 5%
- Retinoids in leukemia and cellular processes 8
-
- Lung Cancer Treatments and Mutations 28
-
- Lymphoma Diagnosis and Treatment 14
-
- Neuroblastoma Research and Treatments 9
- Co-authors
- Carlo Gambacorti‐PasseriniEdoardo MarchesiPhilipp le CoutreMonica CecconSara RedaelliIván Plaza-MenachoFranca FormelliLoredana Cleris
- Cited by
- HematologyGeneticsOncology
- Journals
- Nucleic Acids Research (1 paper)Journal of Biological Chemistry (3 papers)Nature Communications (2 papers)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Luca Mologni
86 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 101
- Hematology 1.1k
- Genetics 784
- Oncology 942
- Rheumatology 481
- Molecular Biology 1.7k
Countries citing papers authored by Luca Mologni
This map shows the geographic impact of Luca Mologni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Mologni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Mologni more than expected).
Fields of papers citing papers by Luca Mologni
This network shows the impact of papers produced by Luca Mologni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Mologni. The network helps show where Luca Mologni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Luca Mologni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 11 | |
| 10 | 2022 | 10 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 27 | |
| 13 | 2021 | 7 | |
| 14 | 2018 | 61 | |
| 15 | 2016 | 17 | |
| 16 | 2014 | 47 | |
| 17 | 2014 | 22 | |
| 18 | 2012 | 71 | |
| 19 | 2011 | 26 | |
| 20 | 2010 | 41 |
About Luca Mologni
Luca Mologni is a scholar working on Hematology, Genetics and Oncology, having authored 91 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (28 papers), Lymphoma Diagnosis and Treatment (14 papers), Chronic Myeloid Leukemia Treatments (13 papers), Cancer-related Molecular Pathways (12 papers), Chronic Lymphocytic Leukemia Research (11 papers), Lung Cancer Research Studies (11 papers), Neuroblastoma Research and Treatments (9 papers) and Retinoids in leukemia and cellular processes (8 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (784 citations) and Oncology (942 citations). Luca Mologni has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Carlo Gambacorti‐Passerini, Edoardo Marchesi, Philipp le Coutre, Monica Ceccon, Sara Redaelli, Iván Plaza-Menacho, Franca Formelli, Loredana Cleris, Elisa Sala and Gonçalo J. M. Cabrita. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.